TG Therapeutics(CH:NKB2)
CH:NKB2
TG Therapeutics earnings date
TG Therapeutics (NKB2) Q2 2026 Earnings Report
0 Followers
CH:NKB2 Q2 2026 EPS Results
- Actual EPS
- CHF 0.04
- Consensus EPS
- CHF 0.25
- Beat/Miss
- Missed by -CHF 0.21
- One Year Ago EPS
- CHF 0.14
CH:NKB2 Q2 2026 Revenue Results
- Actual Revenue
- CHF 198.38M
- Expected Revenue
- CHF 189.66M
- Beat/Miss
- Beat by +CHF 8.72M
- YoY Revenue Growth
- +70.27%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/03/2026
- Time
- Before Open
- Conference Call
- Monday, August 3, 2026
CH:NKB2 Upcoming Earnings
TG Therapeutics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
CH:NKB2 Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:NKB2 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | 0.43- | 0.12 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | 0.300.29 | 2.01 | -85.60% (-1.72) | |
| Aug 03, 2026 | 2026 (Q2) | 0.250.04 | 0.14 | -70.59% (-0.10) | |
| May 06, 2026 | 2026 (Q1) | 0.230.10 | 0.02 | 300.00% (+0.07) | |
| Feb 26, 2026 | 2025 (Q4) | 0.290.12 | 0.12 | -6.67% (-0.01) | |
| Nov 03, 2025 | 2025 (Q3) | 0.182.01 | 0.02 | 12050.00% (+1.99) | |
| Aug 04, 2025 | 2025 (Q2) | 0.170.14 | 0.03 | 325.00% (+0.11) | |
| May 05, 2025 | 2025 (Q1) | 0.140.02 | -0.06 | 142.86% (+0.08) | |
| Mar 03, 2025 | 2024 (Q4) | 0.130.12 | -0.07 | 266.67% (+0.20) | |
| Nov 04, 2024 | 2024 (Q3) | 0.020.02 | 0.6 | -97.26% (-0.59) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

